Acute Lymphoblastic Leukaemia

Acute lymphoblastic leukaemia (ALL) is a type of cancer that commonly affects children over the age of one. It occurs when a lymphocyte precursor, known as a ‘blast cell’, grows abnormally in the bone marrow, leading to a failure of normal blood cell production. This results in peripheral cytopenias, which can cause symptoms such as anaemia, recurrent infections, and purpura. While a raised peripheral white cell count may occur in severe or late-stage disease, it is not common.

Compared to other types of leukaemia and lymphoma, ALL is more likely to present with bone marrow failure symptoms. Acute myeloid leukaemia, for example, is more common in the elderly and presents with a raised peripheral white cell count. Burkitt lymphoma, on the other hand, is a high-grade non-Hodgkin lymphoma that typically presents with lymphadenopathy. Chronic lymphocytic leukaemia is also more common in the elderly and presents with a peripheral lymphocytosis. Langerhans histiocytosis, a condition that affects antigen-presenting cells, is more common in young children and often affects the skin or bones. While it can cause marrow failure, it is a rare occurrence.

In summary, ALL is a type of cancer that affects children and is caused by abnormal growth of blast cells in the bone marrow. It can cause symptoms of bone marrow failure, such as anaemia, recurrent infections, and purpura. While other types of leukaemia and lymphoma may present with different symptoms, ALL is more likely to present with bone marrow failure symptoms.

Vitamin deficiency may occur after an ileocaecal resection.

Vitamin B12 is essential for the development of red blood cells and the maintenance of the nervous system. It is absorbed through the binding of intrinsic factor, which is secreted by parietal cells in the stomach, and actively absorbed in the terminal ileum. A deficiency in vitamin B12 can be caused by pernicious anaemia, post gastrectomy, a vegan or poor diet, disorders or surgery of the terminal ileum, Crohn’s disease, or metformin use.

Symptoms of vitamin B12 deficiency include macrocytic anaemia, a sore tongue and mouth, neurological symptoms, and neuropsychiatric symptoms such as mood disturbances. The dorsal column is usually affected first, leading to joint position and vibration issues before distal paraesthesia.

Management of vitamin B12 deficiency involves administering 1 mg of IM hydroxocobalamin three times a week for two weeks, followed by once every three months if there is no neurological involvement. If a patient is also deficient in folic acid, it is important to treat the B12 deficiency first to avoid subacute combined degeneration of the cord.

Platelets in the UK are obtained through either pooling the platelet component from four units of whole donated blood, known as random donor platelets, or by plasmapheresis from a single donor. These platelets are suspended in 200-300 ml of plasma and can be stored for up to 4 days in the transfusion laboratory, where they are kept agitated at 22oC to maintain their function. One adult platelet pool can increase the normal platelet count (150 – 450 platelets x 109/litre) by 510 platelets x 109/litre. While ABO identical or compatible platelets are preferred for adults, rhesus compatibility is necessary for recipients who are children or women of childbearing age to prevent haemolytic disease of the newborn.

Blood Products and Cell Saver Devices

Blood products are essential in various medical procedures, especially in cases where patients require transfusions due to anaemia or bleeding. Packed red cells, platelet-rich plasma, platelet concentrate, fresh frozen plasma, and cryoprecipitate are some of the commonly used whole blood fractions. Fresh frozen plasma is usually administered to patients with clotting deficiencies, while cryoprecipitate is a rich source of Factor VIII and fibrinogen. Cross-matching is necessary for all blood products, and cell saver devices are used to collect and re-infuse a patient’s own blood lost during surgery.

Cell saver devices come in two types, those that wash the blood cells before re-infusion and those that do not. The former is more expensive and complicated to operate but reduces the risk of re-infusing contaminated blood. The latter avoids the use of donor blood and may be acceptable to Jehovah’s witnesses. However, it is contraindicated in malignant diseases due to the risk of facilitating disease dissemination.

In some surgical patients, the use of warfarin can pose specific problems and may require the use of specialised blood products. Warfarin reversal can be achieved through the administration of vitamin K, fresh frozen plasma, or human prothrombin complex. Fresh frozen plasma is used less commonly now as a first-line warfarin reversal, and human prothrombin complex is preferred due to its rapid action. However, it should be given with vitamin K as factor 6 has a short half-life.

The spleen, which weighs 7oz (150-200g), is approximately 1 inch thick, 3 inches wide, and 5 inches long. It is located between the 9th and 11th ribs. While most of the gut is derived from endodermal tissue, the spleen is unique in that it originates from mesenchymal tissue.

The Anatomy and Function of the Spleen

The spleen is an organ located in the left upper quadrant of the abdomen. Its size can vary depending on the amount of blood it contains, but the typical adult spleen is 12.5cm long and 7.5cm wide, with a weight of 150g. The spleen is almost entirely covered by peritoneum and is separated from the 9th, 10th, and 11th ribs by both diaphragm and pleural cavity. Its shape is influenced by the state of the colon and stomach, with gastric distension causing it to resemble an orange segment and colonic distension causing it to become more tetrahedral.

The spleen has two folds of peritoneum that connect it to the posterior abdominal wall and stomach: the lienorenal ligament and gastrosplenic ligament. The lienorenal ligament contains the splenic vessels, while the short gastric and left gastroepiploic branches of the splenic artery pass through the layers of the gastrosplenic ligament. The spleen is in contact with the phrenicocolic ligament laterally.

The spleen has two main functions: filtration and immunity. It filters abnormal blood cells and foreign bodies such as bacteria, and produces properdin and tuftsin, which help target fungi and bacteria for phagocytosis. The spleen also stores 40% of platelets, reutilizes iron, and stores monocytes. Disorders of the spleen include massive splenomegaly, myelofibrosis, chronic myeloid leukemia, visceral leishmaniasis, malaria, Gaucher’s syndrome, portal hypertension, lymphoproliferative disease, haemolytic anaemia, infection, infective endocarditis, sickle-cell, thalassaemia, and rheumatoid arthritis.

Rectal cancer that occurs below the pectinate line is known to spread to the superficial inguinal lymph nodes. This is because the superficial inguinal nodes are responsible for draining the lymphatic system of the rectum below the pectinate line, as well as the lower limbs, scrotum/vulva.

It is important to note that the inferior mesenteric nodes are not involved in this process, as they primarily drain the hindgut structures from the transverse colon down to the rectum. Similarly, the internal iliac nodes are not involved, as they drain the inferior portion of the rectum, the anal canal superior to the pectinate line, and the pelvic viscera.

Para-aortic nodes are also not involved in the spread of rectal cancer below the pectinate line, as this portion of the rectum does not drain directly to these nodes. Instead, the testes/ovaries drain directly into the para-aortic nodes. Finally, popliteal nodes are not involved, as they only provide lymphatic drainage for the legs.

Lymphatic drainage is the process by which lymphatic vessels carry lymph, a clear fluid containing white blood cells, away from tissues and organs and towards lymph nodes. The lymphatic vessels that drain the skin and follow venous drainage are called superficial lymphatic vessels, while those that drain internal organs and structures follow the arteries and are called deep lymphatic vessels. These vessels eventually lead to lymph nodes, which filter and remove harmful substances from the lymph before it is returned to the bloodstream.

The lymphatic system is divided into two main ducts: the right lymphatic duct and the thoracic duct. The right lymphatic duct drains the right side of the head and right arm, while the thoracic duct drains everything else. Both ducts eventually drain into the venous system.

Different areas of the body have specific primary lymph node drainage sites. For example, the superficial inguinal lymph nodes drain the anal canal below the pectinate line, perineum, skin of the thigh, penis, scrotum, and vagina. The deep inguinal lymph nodes drain the glans penis, while the para-aortic lymph nodes drain the testes, ovaries, kidney, and adrenal gland. The axillary lymph nodes drain the lateral breast and upper limb, while the internal iliac lymph nodes drain the anal canal above the pectinate line, lower part of the rectum, and pelvic structures including the cervix and inferior part of the uterus. The superior mesenteric lymph nodes drain the duodenum and jejunum, while the inferior mesenteric lymph nodes drain the descending colon, sigmoid colon, and upper part of the rectum. Finally, the coeliac lymph nodes drain the stomach.

The inferior mesenteric lymph nodes are responsible for draining the descending colon, which is where the initial lesion was identified during colonoscopy. Understanding the lymphatic drainage pathway is crucial in cancer diagnosis and treatment, as it can help predict potential sites of metastasis.

For instance, cancers affecting the stomach, such as gastric adenocarcinomas or gastrointestinal stromal tumors, would be drained by the coeliac lymph nodes. On the other hand, the internal iliac lymph nodes are responsible for draining the anal canal (above the pectinate line), the lower part of the rectum, and other pelvic structures like the cervix. Therefore, cancers originating from these areas, such as squamous cell carcinoma of the cervix, would spread through these nodes.

Para-aortic lymph nodes, on the other hand, drain cancers arising from the testes, ovaries, kidneys, and adrenal glands. Examples of these cancers include germ cell tumors (ovaries and testes), renal cell carcinomas, and phaeochromocytomas.

Finally, the superior mesenteric lymph nodes are responsible for draining lesions arising in the duodenum and jejunum, such as small bowel adenocarcinomas and carcinoid tumors.

Lymphatic drainage is the process by which lymphatic vessels carry lymph, a clear fluid containing white blood cells, away from tissues and organs and towards lymph nodes. The lymphatic vessels that drain the skin and follow venous drainage are called superficial lymphatic vessels, while those that drain internal organs and structures follow the arteries and are called deep lymphatic vessels. These vessels eventually lead to lymph nodes, which filter and remove harmful substances from the lymph before it is returned to the bloodstream.

The lymphatic system is divided into two main ducts: the right lymphatic duct and the thoracic duct. The right lymphatic duct drains the right side of the head and right arm, while the thoracic duct drains everything else. Both ducts eventually drain into the venous system.

Different areas of the body have specific primary lymph node drainage sites. For example, the superficial inguinal lymph nodes drain the anal canal below the pectinate line, perineum, skin of the thigh, penis, scrotum, and vagina. The deep inguinal lymph nodes drain the glans penis, while the para-aortic lymph nodes drain the testes, ovaries, kidney, and adrenal gland. The axillary lymph nodes drain the lateral breast and upper limb, while the internal iliac lymph nodes drain the anal canal above the pectinate line, lower part of the rectum, and pelvic structures including the cervix and inferior part of the uterus. The superior mesenteric lymph nodes drain the duodenum and jejunum, while the inferior mesenteric lymph nodes drain the descending colon, sigmoid colon, and upper part of the rectum. Finally, the coeliac lymph nodes drain the stomach.

Ulcerative colitis, a type of inflammatory bowel disease characterized by bloody diarrhea, can be treated with various medications such as sulfasalazine, infliximab, 6-mercaptopurine, and in severe cases, a colectomy. 6-mercaptopurine is a purine analogue that is activated by HGPRTase, leading to decreased purine synthesis and reduced DNA synthesis. It is commonly used to treat non-malignant conditions like systemic lupus erythematosus, rheumatoid arthritis, and inflammatory bowel disease. On the other hand, 5-fluorouracil is a pyrimidine analogue that acts as an antimetabolite, interfering with DNA synthesis, and is used to treat colorectal and pancreatic cancer. Methotrexate, an antimetabolite that acts as a folic acid analogue, is widely used in many malignancies and non-malignant conditions such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. Bleomycin, doxorubicin, and daunorubicin cause free radical formation, leading to breaks in the DNA strand, while busulfan is an alkylating agent that causes cross-links in the DNA and is typically used to ablate a patient’s bone marrow before a bone marrow transplant.

Cytotoxic agents are drugs that are used to kill cancer cells. There are several types of cytotoxic agents, each with their own mechanism of action and potential adverse effects. Alkylating agents, such as cyclophosphamide, work by causing cross-linking in DNA. However, they can also cause haemorrhagic cystitis, myelosuppression, and transitional cell carcinoma. Cytotoxic antibiotics, like bleomycin and anthracyclines, degrade preformed DNA and stabilize DNA-topoisomerase II complex, respectively. However, they can also cause lung fibrosis and cardiomyopathy. Antimetabolites, such as methotrexate and fluorouracil, inhibit dihydrofolate reductase and thymidylate synthesis, respectively. However, they can also cause myelosuppression, mucositis, and liver or lung fibrosis. Drugs that act on microtubules, like vincristine and docetaxel, inhibit the formation of microtubules and prevent microtubule depolymerisation & disassembly, respectively. However, they can also cause peripheral neuropathy, myelosuppression, and paralytic ileus. Topoisomerase inhibitors, like irinotecan, inhibit topoisomerase I, which prevents relaxation of supercoiled DNA. However, they can also cause myelosuppression. Other cytotoxic drugs, such as cisplatin and hydroxyurea, cause cross-linking in DNA and inhibit ribonucleotide reductase, respectively. However, they can also cause ototoxicity, peripheral neuropathy, hypomagnesaemia, and myelosuppression.

Prognostic Factors in Acute Lymphoblastic Leukemia

Younger patients with acute lymphoblastic leukemia (ALL) have a better prognosis than older patients. In fact, the cure rate in children is around 90%, while it is less than 40% in adults. Additionally, male patients tend to fare worse than females, and they require a longer maintenance dose of chemotherapy (3 years versus 2 years). Interestingly, the Philadelphia chromosome, which is an effective treatment target in chronic myeloid leukemia, is actually a poor prognostic marker in ALL. Finally, higher white cell counts are associated with adverse outcomes, particularly if the count exceeds 100 ×106/ml.

Overall, these prognostic factors can help clinicians predict the likelihood of a successful outcome in patients with ALL. By taking these factors into account, healthcare providers can tailor treatment plans to each patient’s individual needs and improve their chances of a positive outcome.

In coeliac disease, the spleen may undergo atrophy and Howell-Jolly bodies may be observed in red blood cells. Histiocytosis X includes Letterer-Siwe disease, which involves the excessive growth of macrophages.

The Anatomy and Function of the Spleen

The spleen is an organ located in the left upper quadrant of the abdomen. Its size can vary depending on the amount of blood it contains, but the typical adult spleen is 12.5cm long and 7.5cm wide, with a weight of 150g. The spleen is almost entirely covered by peritoneum and is separated from the 9th, 10th, and 11th ribs by both diaphragm and pleural cavity. Its shape is influenced by the state of the colon and stomach, with gastric distension causing it to resemble an orange segment and colonic distension causing it to become more tetrahedral.

The spleen has two folds of peritoneum that connect it to the posterior abdominal wall and stomach: the lienorenal ligament and gastrosplenic ligament. The lienorenal ligament contains the splenic vessels, while the short gastric and left gastroepiploic branches of the splenic artery pass through the layers of the gastrosplenic ligament. The spleen is in contact with the phrenicocolic ligament laterally.

The spleen has two main functions: filtration and immunity. It filters abnormal blood cells and foreign bodies such as bacteria, and produces properdin and tuftsin, which help target fungi and bacteria for phagocytosis. The spleen also stores 40% of platelets, reutilizes iron, and stores monocytes. Disorders of the spleen include massive splenomegaly, myelofibrosis, chronic myeloid leukemia, visceral leishmaniasis, malaria, Gaucher’s syndrome, portal hypertension, lymphoproliferative disease, haemolytic anaemia, infection, infective endocarditis, sickle-cell, thalassaemia, and rheumatoid arthritis.

The inheritance of Haemophilia A and B is crucial in identifying individuals who are at risk of developing the condition. Haemophilia A and B are genetic disorders that are inherited in an X-linked recessive manner. Haemophilia A is caused by a deficiency in clotting factor VIII, while haemophilia B is caused by a deficiency in clotting factor IX.

On the other hand, haemophilia C, which is caused by a deficiency in clotting factor XI, is primarily inherited in an autosomal recessive manner. In X-linked recessive conditions like haemophilia B, males are more likely to be affected than females. This is because males only need one abnormal copy of the gene, which is carried on the X chromosome, to be affected.

Females, on the other hand, can be carriers of the condition if they carry one normal and one abnormal copy of the gene. While carriers can have clotting abnormalities, these are usually milder than those seen in affected individuals. Men cannot pass the condition to their sons, but they will pass on the abnormal X chromosome to all their daughters, who will be carriers.

Female carriers can pass on the condition to around half their sons, and half their daughters will be carriers. Females can only be affected if they are the offspring of an affected male and a carrier female. In summary, the inheritance of haemophilia A and B is crucial in identifying individuals who are at risk of developing the condition. It also helps in providing appropriate genetic counseling and management for affected individuals and their families.

Mast cells originate from common myeloid progenitor cells.

Haematopoiesis: The Generation of Immune Cells

Haematopoiesis is the process by which immune cells are produced from haematopoietic stem cells in the bone marrow. These stem cells give rise to two main types of progenitor cells: myeloid and lymphoid progenitor cells. All immune cells are derived from these progenitor cells.

The myeloid progenitor cells generate cells such as macrophages/monocytes, dendritic cells, neutrophils, eosinophils, basophils, and mast cells. On the other hand, lymphoid progenitor cells give rise to T cells, NK cells, B cells, and dendritic cells.

This process is essential for the proper functioning of the immune system. Without haematopoiesis, the body would not be able to produce the necessary immune cells to fight off infections and diseases. Understanding haematopoiesis is crucial in developing treatments for diseases that affect the immune system.

The para-aortic nodes are responsible for receiving lymph drainage from the testes. This is because the testes develop in the abdomen and move down the posterior abdominal wall during fetal development, leading to their lymphatic drainage coming from the para-aortic lymph nodes. Therefore, the para-aortic nodes are the most likely location for lymphatic spread from the testes.

The inferior mesenteric nodes are not responsible for lymph drainage from the testes as they primarily drain hindgut structures such as the transverse colon down to the rectum. Similarly, the internal iliac nodes drain the inferior portion of the rectum, the anal canal superior to the pectinate line, and the pelvic viscera, but not the testes. The posterior mediastinal chain is also not responsible for lymph drainage from the testes as it drains the oesophagus, mediastinum, and posterior surface of the diaphragm.

Lymphatic drainage is the process by which lymphatic vessels carry lymph, a clear fluid containing white blood cells, away from tissues and organs and towards lymph nodes. The lymphatic vessels that drain the skin and follow venous drainage are called superficial lymphatic vessels, while those that drain internal organs and structures follow the arteries and are called deep lymphatic vessels. These vessels eventually lead to lymph nodes, which filter and remove harmful substances from the lymph before it is returned to the bloodstream.

The lymphatic system is divided into two main ducts: the right lymphatic duct and the thoracic duct. The right lymphatic duct drains the right side of the head and right arm, while the thoracic duct drains everything else. Both ducts eventually drain into the venous system.

Different areas of the body have specific primary lymph node drainage sites. For example, the superficial inguinal lymph nodes drain the anal canal below the pectinate line, perineum, skin of the thigh, penis, scrotum, and vagina. The deep inguinal lymph nodes drain the glans penis, while the para-aortic lymph nodes drain the testes, ovaries, kidney, and adrenal gland. The axillary lymph nodes drain the lateral breast and upper limb, while the internal iliac lymph nodes drain the anal canal above the pectinate line, lower part of the rectum, and pelvic structures including the cervix and inferior part of the uterus. The superior mesenteric lymph nodes drain the duodenum and jejunum, while the inferior mesenteric lymph nodes drain the descending colon, sigmoid colon, and upper part of the rectum. Finally, the coeliac lymph nodes drain the stomach.

To divide the breast into four quadrants, one can visualize a vertical and horizontal line passing through the nipple. The superior lateral quadrant is where breast malignancies are most frequently detected. During a breast examination, it is crucial to palpate all quadrants and the axillary tail (which is part of the superior lateral quadrant). The quadrants also play a significant role in lymphatic drainage, as the medial quadrants can drain to the opposite side.

Breast Cancer Pathology: Understanding the Histological Features

Breast cancer pathology involves examining the histological features of the cancer cells to determine the underlying diagnosis. The invasive component of breast cancer is typically made up of ductal cells, although invasive lobular cancer may also occur. In situ lesions, such as DCIS, may also be present.

When examining breast cancer pathology, several typical changes are seen in conjunction with invasive breast cancer. These include nuclear pleomorphism, coarse chromatin, angiogenesis, invasion of the basement membrane, dystrophic calcification (which may be seen on mammography), abnormal mitoses, vascular invasion, and lymph node metastasis.

To grade the primary tumor, a scale of 1-3 is used, with 1 being the most benign lesion and 3 being the most poorly differentiated. Immunohistochemistry for estrogen receptor and herceptin status is routinely performed to further understand the cancer’s characteristics.

The grade, lymph node stage, and size are combined to provide the Nottingham prognostic index, which helps predict the patient’s prognosis and guide treatment decisions. Understanding the histological features of breast cancer is crucial in determining the best course of treatment for patients.

Breast Cancer Pathology: Understanding the Histological Features

Breast cancer pathology involves examining the histological features of the cancer cells to determine the underlying diagnosis. The invasive component of breast cancer is typically made up of ductal cells, although invasive lobular cancer may also occur. In situ lesions, such as DCIS, may also be present.

When examining breast cancer pathology, several typical changes are seen in conjunction with invasive breast cancer. These include nuclear pleomorphism, coarse chromatin, angiogenesis, invasion of the basement membrane, dystrophic calcification (which may be seen on mammography), abnormal mitoses, vascular invasion, and lymph node metastasis.

To grade the primary tumor, a scale of 1-3 is used, with 1 being the most benign lesion and 3 being the most poorly differentiated. Immunohistochemistry for estrogen receptor and herceptin status is routinely performed to further understand the cancer’s characteristics.

The grade, lymph node stage, and size are combined to provide the Nottingham prognostic index, which helps predict the patient’s prognosis and guide treatment decisions. Understanding the histological features of breast cancer is crucial in determining the best course of treatment for patients.

The cervix primarily drains into the internal iliac lymph nodes. The deep inguinal lymph nodes do not drain the cervix, but they do drain the clitoris and glans penis. The external iliac lymph nodes are not significantly involved in the lymphatic drainage of the cervix, but they do play a role in the drainage of the bladder fundus, prostate, and adductor region of the thigh. The para-aortic nodes drain the ovaries, but not the cervix. The superficial inguinal lymph nodes are not involved in the drainage of the cervix, but they are important in the drainage of the anal canal (below the pectinate line), scrotum, and perineum.

Lymphatic drainage is the process by which lymphatic vessels carry lymph, a clear fluid containing white blood cells, away from tissues and organs and towards lymph nodes. The lymphatic vessels that drain the skin and follow venous drainage are called superficial lymphatic vessels, while those that drain internal organs and structures follow the arteries and are called deep lymphatic vessels. These vessels eventually lead to lymph nodes, which filter and remove harmful substances from the lymph before it is returned to the bloodstream.

The lymphatic system is divided into two main ducts: the right lymphatic duct and the thoracic duct. The right lymphatic duct drains the right side of the head and right arm, while the thoracic duct drains everything else. Both ducts eventually drain into the venous system.

Different areas of the body have specific primary lymph node drainage sites. For example, the superficial inguinal lymph nodes drain the anal canal below the pectinate line, perineum, skin of the thigh, penis, scrotum, and vagina. The deep inguinal lymph nodes drain the glans penis, while the para-aortic lymph nodes drain the testes, ovaries, kidney, and adrenal gland. The axillary lymph nodes drain the lateral breast and upper limb, while the internal iliac lymph nodes drain the anal canal above the pectinate line, lower part of the rectum, and pelvic structures including the cervix and inferior part of the uterus. The superior mesenteric lymph nodes drain the duodenum and jejunum, while the inferior mesenteric lymph nodes drain the descending colon, sigmoid colon, and upper part of the rectum. Finally, the coeliac lymph nodes drain the stomach.

Salmonella and Staphylococcus aureus as Causes of Osteomyelitis

Salmonella species are responsible for more than half of osteomyelitis cases in patients with sickle cell disease. The higher incidence of salmonella infections is due to various factors. The gut wall’s micro-infarcts allow the bacteria to enter the bloodstream, causing infection. Additionally, impaired splenic function leads to a weakened immune response against the pathogen.

On the other hand, Staphylococcus aureus is the most common organism that causes osteomyelitis in the general population. Although other organisms can also cause osteomyelitis, they are less frequently implicated.

Antiphospholipid syndrome is a condition where the body’s immune system produces antibodies that cause blood clots and pregnancy-related complications. The diagnosis requires one clinical event and two positive blood tests spaced at least 3 months apart. The antibodies associated with this syndrome are lupus anticoagulant, anti-cardiolipin, and anti-β2-glycoprotein. Antiphospholipid syndrome can be primary or secondary, with the latter occurring in conjunction with other autoimmune diseases. In severe cases, the condition can lead to organ failure, known as catastrophic antiphospholipid syndrome. Treatment typically involves anticoagulant medication such as heparin, while warfarin is avoided during pregnancy due to its teratogenic effects.

Hypercoagulability is a condition where the blood has an increased tendency to clot. There are several types of thrombophilia, each with their own unique features. Antithrombin deficiency is a rare genetic defect that increases the risk of thrombotic events by 10 times. Heparin may not be effective in treating this condition as it works via antithrombin. Protein C and S deficiency, which accounts for up to 5% of thrombotic episodes, occurs when there is a lack of natural anticoagulants that are produced by the liver. Factor V Leiden is the most common genetic defect accounting for deep vein thrombosis (DVT) and may account for up to 20% or more of thrombotic episodes. Antiphospholipid syndrome is a multi-organ disease that can involve pregnancy and cause both arterial and venous thrombosis. It is characterized by either Lupus anticoagulant or Anti cardiolipin antibodies, and requires anticoagulation with an INR between 3 and 4.

In summary, hypercoagulability is a condition where the blood has an increased tendency to clot. There are several types of thrombophilia, each with their own unique features. Antithrombin deficiency, protein C and S deficiency, factor V Leiden, and antiphospholipid syndrome are some of the most common types of thrombophilia. It is important to identify and treat these conditions to prevent thrombotic events.

As long as the patient’s Hb level is 7 or higher, transfusion may not be necessary for their management. However, this threshold may vary depending on individual factors such as co-existing medical conditions. It is important to avoid using old blood during massive transfusions as its effectiveness may be compromised.

Blood Products and Cell Saver Devices

Blood products are essential in various medical procedures, especially in cases where patients require transfusions due to anaemia or bleeding. Packed red cells, platelet-rich plasma, platelet concentrate, fresh frozen plasma, and cryoprecipitate are some of the commonly used whole blood fractions. Fresh frozen plasma is usually administered to patients with clotting deficiencies, while cryoprecipitate is a rich source of Factor VIII and fibrinogen. Cross-matching is necessary for all blood products, and cell saver devices are used to collect and re-infuse a patient’s own blood lost during surgery.

Cell saver devices come in two types, those that wash the blood cells before re-infusion and those that do not. The former is more expensive and complicated to operate but reduces the risk of re-infusing contaminated blood. The latter avoids the use of donor blood and may be acceptable to Jehovah’s witnesses. However, it is contraindicated in malignant diseases due to the risk of facilitating disease dissemination.

In some surgical patients, the use of warfarin can pose specific problems and may require the use of specialised blood products. Warfarin reversal can be achieved through the administration of vitamin K, fresh frozen plasma, or human prothrombin complex. Fresh frozen plasma is used less commonly now as a first-line warfarin reversal, and human prothrombin complex is preferred due to its rapid action. However, it should be given with vitamin K as factor 6 has a short half-life.

Chronic hypoxia caused by COPD is a secondary factor leading to polycythaemia in this patient. While an anterior ST elevation MI is likely the acute issue, it would not explain the polycythaemia. Asthma is not a cause of polycythaemia and would not be responsible for the ECG changes. An inferior MI would not be associated with polycythaemia and would only cause ST elevation in leads II, III, and aVF.

Polycythaemia is a condition that can be classified as relative, primary (polycythaemia rubra vera), or secondary. Relative polycythaemia can be caused by dehydration or stress, such as in Gaisbock syndrome. Primary polycythaemia rubra vera is a rare blood disorder that causes the bone marrow to produce too many red blood cells. Secondary polycythaemia can be caused by conditions such as COPD, altitude, obstructive sleep apnoea, or excessive erythropoietin production due to certain tumors or growths. To distinguish between true polycythaemia and relative polycythaemia, red cell mass studies may be used. In true polycythaemia, the total red cell mass in males is greater than 35 ml/kg and in women is greater than 32 ml/kg. Uterine fibroids may also cause polycythaemia indirectly by causing menorrhagia, but this is rarely a clinical problem.

Inheritance of Lynch syndrome follows an autosomal dominant pattern and is identified by the presence of microsatellite instability in DNA mismatch repair genes. Patients with Lynch syndrome are more prone to developing poorly differentiated right-sided colonic tumors.

Genetic Conditions and Their Association with Surgical Diseases

Li-Fraumeni Syndrome is an autosomal dominant genetic condition caused by mutations in the p53 tumour suppressor gene. Individuals with this syndrome have a high incidence of malignancies, particularly sarcomas and leukaemias. The diagnosis is made when an individual develops sarcoma under the age of 45 or when a first-degree relative is diagnosed with any cancer below the age of 45 and another family member develops malignancy under the age of 45 or sarcoma at any age.

BRCA 1 and 2 are genetic conditions carried on chromosome 17 and chromosome 13, respectively. These conditions are linked to developing breast cancer with a 60% risk and an associated risk of developing ovarian cancer with a 55% risk for BRCA 1 and 25% risk for BRCA 2. BRCA2 mutation is also associated with prostate cancer in men.

Lynch Syndrome is another autosomal dominant genetic condition that causes individuals to develop colonic cancer and endometrial cancer at a young age. 80% of affected individuals will get colonic and/or endometrial cancer. High-risk individuals may be identified using the Amsterdam criteria, which include three or more family members with a confirmed diagnosis of colorectal cancer, two successive affected generations, and one or more colon cancers diagnosed under the age of 50 years.

Gardners syndrome is an autosomal dominant familial colorectal polyposis that causes multiple colonic polyps. Extra colonic diseases include skull osteoma, thyroid cancer, and epidermoid cysts. Desmoid tumours are seen in 15% of individuals with this syndrome. Due to colonic polyps, most patients will undergo colectomy to reduce the risk of colorectal cancer. It is now considered a variant of familial adenomatous polyposis coli.

Overall, these genetic conditions have a significant association with surgical diseases, and early identification and management can help reduce the risk of malignancies and other associated conditions.

Syndrome of Inappropriate ADH Secretion

Syndrome of inappropriate ADH secretion (SIADH) is a condition characterized by low levels of sodium in the blood. This is caused by the overproduction of antidiuretic hormone (ADH) by the posterior pituitary gland. Tumors such as bronchial carcinoma can cause the ectopic elaboration of ADH, leading to dilutional hyponatremia. The diagnosis of SIADH is one of exclusion, but it can be supported by a high urine sodium concentration with high urine osmolality.

Hypoadrenalism is less likely to cause hyponatremia, as it is usually associated with hyperkalemia and mild hyperuricemia. On the other hand, diabetes insipidus is a condition where the kidneys are unable to reabsorb water, leading to excessive thirst and urination.

It is important to diagnose and treat SIADH promptly to prevent complications such as seizures, coma, and even death. Treatment options include fluid restriction, medications to block the effects of ADH, and addressing the underlying cause of the condition.

In conclusion, SIADH is a condition that can cause low levels of sodium in the blood due to the overproduction of ADH. It is important to differentiate it from other conditions that can cause hyponatremia and to treat it promptly to prevent complications.

There are five potential disease phenotypes of alpha thalassaemia based on the number of faulty or missing globin alleles in a patient’s genotype. These include silent carrier (alpha(+) heterozygous) for one missing allele, alpha thalassaemia trait: alpha(0) heterozygous for two missing alleles, alpha thalassaemia trait: alpha(+) homozygous for two missing alleles, haemoglobin H disease for three missing alleles, and (–/–) for four missing alleles.

Understanding Alpha-Thalassaemia

Alpha-thalassaemia is a genetic disorder that results from a deficiency of alpha chains in haemoglobin. The condition is caused by a mutation in the alpha-globulin genes located on chromosome 16. The severity of the disease depends on the number of alpha globulin alleles affected. If one or two alleles are affected, the blood picture would be hypochromic and microcytic, but the haemoglobin level would typically be normal. However, if three alleles are affected, it results in a hypochromic microcytic anaemia with splenomegaly, which is known as Hb H disease. In the case of all four alleles being affected, which is known as homozygote, it can lead to death in utero, also known as hydrops fetalis or Bart’s hydrops. Understanding the different levels of severity of alpha-thalassaemia is crucial in diagnosing and managing the condition.

Based on his symptoms of night sweats, weight loss, fatigue, and splenomegaly, the patient is likely suffering from chronic myelogenous leukemia (CML). This type of leukemia is characterized by a specific translocation between chromosome 9 and 22, known as the Philadelphia chromosome. Other translocations are associated with different types of blood cancers, such as t(15;17) in acute promyelocytic leukemia, t(8;14) in Burkitt’s lymphoma, and t(11;14) in mantle cell lymphoma.

Genetics of Haematological Malignancies

Haematological malignancies are cancers that affect the blood, bone marrow, and lymphatic system. These cancers are often associated with specific genetic abnormalities, such as translocations. Here are some common translocations and their associated haematological malignancies:

– Philadelphia chromosome (t(9;22)): This translocation is present in more than 95% of patients with chronic myeloid leukaemia (CML). It results in the fusion of the Abelson proto-oncogene with the BCR gene on chromosome 22, creating the BCR-ABL gene. This gene codes for a fusion protein with excessive tyrosine kinase activity, which is a poor prognostic indicator in acute lymphoblastic leukaemia (ALL).

– t(15;17): This translocation is seen in acute promyelocytic leukaemia (M3) and involves the fusion of the PML and RAR-alpha genes.

– t(8;14): Burkitt’s lymphoma is associated with this translocation, which involves the translocation of the MYC oncogene to an immunoglobulin gene.

– t(11;14): Mantle cell lymphoma is associated with the deregulation of the cyclin D1 (BCL-1) gene.

– t(14;18): Follicular lymphoma is associated with increased BCL-2 transcription due to this translocation.

Understanding the genetic abnormalities associated with haematological malignancies is important for diagnosis, prognosis, and treatment.

Methotrexate treatment can lead to megaloblastic macrocytic anemia due to a deficiency of folate.

The patient’s low hemoglobin and high MCV indicate macrocytic anemia, which can be caused by various factors such as alcohol abuse, hypothyroidism, aplastic anemia, and megaloblastic anemia due to a deficiency of vitamin B12 and/or folate. In this case, the patient has a history of rheumatoid arthritis and takes methotrexate weekly, which inhibits dihydrofolate reductase and causes a deficiency of folate. Therefore, folate deficiency is the most probable cause of the patient’s anemia.

Alcohol excess is an incorrect option as it usually requires larger quantities of alcohol to cause macrocytic anemia.

Anaemia of chronic disease is an incorrect option as it typically results in normocytic or microcytic anemia, not macrocytic anemia.

Iron deficiency anemia is an incorrect option as it causes microcytic anemia, and the MCV value would be lower than expected.

Understanding Macrocytic Anaemia

Macrocytic anaemia is a type of anaemia that can be classified into two categories: megaloblastic and normoblastic. Megaloblastic anaemia is caused by a deficiency in vitamin B12 or folate, which leads to the production of abnormally large red blood cells in the bone marrow. This type of anaemia can also be caused by certain medications, alcohol, liver disease, hypothyroidism, pregnancy, and myelodysplasia.

On the other hand, normoblastic anaemia is caused by an increase in the number of immature red blood cells, known as reticulocytes, in the bone marrow. This can occur as a result of certain medications, such as methotrexate, or in response to other underlying medical conditions.

It is important to identify the underlying cause of macrocytic anaemia in order to provide appropriate treatment. This may involve addressing any nutritional deficiencies, managing underlying medical conditions, or adjusting medications. With proper management, most cases of macrocytic anaemia can be successfully treated.

Understanding Antithrombin III Deficiency

Antithrombin III deficiency is a genetic condition that affects approximately 1 in 3,000 people. It is inherited in an autosomal dominant manner. This condition occurs when the body does not produce enough antithrombin III, a protein that helps to prevent blood clots by inhibiting certain clotting factors. Some patients with this deficiency have a shortage of normal antithrombin III, while others produce abnormal antithrombin III.

People with antithrombin III deficiency are at an increased risk of developing recurrent venous thromboses, which are blood clots that form in the veins. While arterial thromboses can also occur, they are less common. To manage this condition, patients may need to take warfarin for the rest of their lives to prevent thromboembolic events. During pregnancy, heparin may be used instead. Antithrombin III concentrates may also be used during surgery or childbirth.

It is important to note that patients with antithrombin III deficiency have a degree of resistance to heparin, so anti-Xa levels should be monitored carefully to ensure adequate anticoagulation. Compared to other inherited thrombophilias, antithrombin III deficiency is less common but has a higher relative risk of venous thromboembolism. Understanding this condition and its management is crucial for those affected and their healthcare providers.

DIC, also known as consumptive coagulopathy, is a condition where the coagulation cascade is overactivated, leading to unchecked bleeding. This is due to the depletion of clotting mechanisms. Normally, clot formation and breakdown are balanced, with thrombin playing a key role in both processes. In DIC, patients may have prolonged coagulation times, thrombocytopenia, high levels of fibrin degradation products, elevated D-dimer levels, and microangiopathic pathology on peripheral smears. The excess fibrin strands in the intravascular circulation cause mechanical damage to red blood cells, resulting in schistocyte formation, thrombocytopenia, and consumption of clotting factors. Bite cells are abnormally shaped red blood cells with semicircular portions removed from the cell margin, seen in G6PD deficiency. Dacrocytes are teardrop-shaped cells seen in myelofibrosis and marrow disorders, while elliptocytes are red cells varying in shape from elongated to oval, seen in various disorders.

Disseminated Intravascular Coagulation: A Condition of Simultaneous Coagulation and Haemorrhage

Disseminated intravascular coagulation (DIC) is a medical condition characterized by simultaneous coagulation and haemorrhage. It is caused by the initial formation of thrombi that consume clotting factors and platelets, ultimately leading to bleeding. DIC can be caused by various factors such as infection, malignancy, trauma, liver disease, and obstetric complications.

Clinically, bleeding is usually the dominant feature of DIC, accompanied by bruising, ischaemia, and organ failure. Blood tests can reveal prolonged clotting times, thrombocytopenia, decreased fibrinogen, and increased fibrinogen degradation products. The treatment of DIC involves addressing the underlying cause and providing supportive management.

In summary, DIC is a serious medical condition that requires prompt diagnosis and management. It is important to identify the underlying cause and provide appropriate treatment to prevent further complications. With proper care and management, patients with DIC can recover and regain their health.

Possible GI Malignancy in a Man with Weight Loss and Microcytic Anaemia

This man is experiencing weight loss and has an unexplained microcytic anaemia. The most probable cause of his blood loss is from the gastrointestinal (GI) tract, as there is no other apparent explanation. This could be due to an occult GI malignancy, which is why the recommended initial investigations are upper and lower GI endoscopy. These tests will help to identify any potential sources of bleeding in the GI tract and determine if there is an underlying malignancy. It is important to diagnose and treat any potential malignancy as early as possible to improve the patient’s prognosis. Therefore, prompt investigation and management are crucial in this case.

The ovarian vessels directly branch from the aorta to supply ovarian tumours. Meanwhile, the internal and external iliac nodes are responsible for draining the cervix.

Para-aortic Lymphadenopathy and its Association with Metastasis

Para-aortic lymphadenopathy is a condition where the lymph nodes located near the aorta become enlarged due to the spread of cancer cells. This condition is commonly associated with the metastasis of cancer cells from various organs, including the testis, ovary, and uterine fundus. In these cases, the cancer cells spread to the para-aortic lymph nodes at an early stage of the disease.

However, it is important to note that para-aortic nodal disease may also occur as a result of cancer cells spreading from other organs. In these cases, the para-aortic nodal disease represents a much later stage of the disease, as other nodal stations are involved earlier.

Overall, para-aortic lymphadenopathy is a significant concern for individuals with cancer, as it can indicate the spread of cancer cells to other parts of the body. Early detection and treatment of para-aortic nodal disease can improve the chances of successful treatment and recovery.

The individual has been diagnosed with tumour lysis syndrome, which is a dangerous complication that can arise when commencing chemotherapy for cancer, particularly for lymphoma and leukaemia. Tumour lysis syndrome encompasses a range of metabolic imbalances, such as elevated levels of potassium, phosphates, and uric acid, as well as reduced levels of calcium. These imbalances can result in severe complications, including acute kidney failure, irregular heartbeats, and seizures.

Understanding Tumour Lysis Syndrome

Tumour lysis syndrome (TLS) is a life-threatening condition that can occur during the treatment of high-grade lymphomas and leukaemias. It is caused by the breakdown of tumour cells and the release of chemicals into the bloodstream. While it can occur without chemotherapy, it is usually triggered by the introduction of combination chemotherapy. Patients at high risk of TLS should be given prophylactic medication such as IV allopurinol or IV rasburicase to prevent the potentially deadly effects of tumour cell lysis.

TLS leads to a high potassium and high phosphate level in the presence of a low calcium. It should be suspected in any patient presenting with an acute kidney injury in the presence of a high phosphate and high uric acid level. From 2004, TLS has been graded using the Cairo-Bishop scoring system, which takes into account laboratory and clinical factors.

It is important to be aware of TLS and take preventative measures to avoid its potentially fatal consequences. By understanding the causes and symptoms of TLS, healthcare professionals can provide appropriate treatment and improve patient outcomes.

The likely cause of the patient’s megaloblastic macrocytic anaemia is Methotrexate therapy, which can result in folate deficiency. This drug is commonly used in the treatment of rheumatoid arthritis. Lead poisoning, high alcohol intake, and hyperthyroidism are not likely causes of this type of anaemia. Pernicious anaemia, an autoimmune condition that can lead to B12 deficiency, is also not the cause in this case as the patient has normal B12 levels.

Understanding Macrocytic Anaemia

Macrocytic anaemia is a type of anaemia that can be classified into two categories: megaloblastic and normoblastic. Megaloblastic anaemia is caused by a deficiency in vitamin B12 or folate, which leads to the production of abnormally large red blood cells in the bone marrow. This type of anaemia can also be caused by certain medications, alcohol, liver disease, hypothyroidism, pregnancy, and myelodysplasia.

On the other hand, normoblastic anaemia is caused by an increase in the number of immature red blood cells, known as reticulocytes, in the bone marrow. This can occur as a result of certain medications, such as methotrexate, or in response to other underlying medical conditions.

It is important to identify the underlying cause of macrocytic anaemia in order to provide appropriate treatment. This may involve addressing any nutritional deficiencies, managing underlying medical conditions, or adjusting medications. With proper management, most cases of macrocytic anaemia can be successfully treated.